Intra Cellular Therapies shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intra Cellular Therapies by Kennedy Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.0M | 27k | 71.62 |
2023-09-30 | $1.6M | 30k | 52.09 |
2023-06-30 | $4.4M | 70k | 63.32 |
2023-03-31 | $5.9M | 108k | 54.15 |
2022-12-31 | $16M | 309k | 52.92 |
2022-09-30 | $15M | 324k | 46.53 |
2022-06-30 | $15M | 253k | 57.08 |
2022-03-31 | $15M | 241k | 61.19 |
2021-12-31 | $11M | 205k | 52.34 |
2021-09-30 | $3.7M | 98k | 37.28 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management